Cargando…

Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro

BACKGROUND: The initial steps of stem Leydig cell differentiation into steroid producing progenitor cells are thought to take place independent of luteinizing hormone (LH), under the influence of locally produced factors such as leukaemia inhibitory factor (LIF), platelet derived growth factor A and...

Descripción completa

Detalles Bibliográficos
Autores principales: Teerds, Katja J, van Dissel-Emiliani, Federica MF, De Miguel, Maria P, de Boer-Brouwer, Mieke, Körting, Lina M, Rijntjes, Eddy
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174940/
https://www.ncbi.nlm.nih.gov/pubmed/17996055
http://dx.doi.org/10.1186/1477-7827-5-43
_version_ 1782145393244504064
author Teerds, Katja J
van Dissel-Emiliani, Federica MF
De Miguel, Maria P
de Boer-Brouwer, Mieke
Körting, Lina M
Rijntjes, Eddy
author_facet Teerds, Katja J
van Dissel-Emiliani, Federica MF
De Miguel, Maria P
de Boer-Brouwer, Mieke
Körting, Lina M
Rijntjes, Eddy
author_sort Teerds, Katja J
collection PubMed
description BACKGROUND: The initial steps of stem Leydig cell differentiation into steroid producing progenitor cells are thought to take place independent of luteinizing hormone (LH), under the influence of locally produced factors such as leukaemia inhibitory factor (LIF), platelet derived growth factor A and stem cell factor. For the formation of a normal sized Leydig cell population in the adult testis, the presence of LH appears to be essential. Oncostatin M (OSM) is a multifunctional cytokine and member of the interleukin (IL)-6 family that also includes other cytokines such as LIF. In the rat OSM is highly expressed in the late fetal and neonatal testis, and may thus be a candidate factor involved in Leydig cell progenitor formation. METHODS: Interstitial cells were isolated from 13-day-old rat testes and cultured for 1, 3 or 8 days in the presence of different doses of OSM (range: 0.01 to 10 ng/ml) alone or in combination with LH (1 ng/ml). The effects of OSM and LH on cell proliferation were determined by incubating the cultures with [3H]thymidine or bromodeoxyuridine (BrdU). Developing progenitor cells were identified histochemically by the presence of the marker enzyme 3beta-hydroxysteroid dehydrogenase (3beta-HSD). RESULTS: OSM, when added at a dose of 10 ng/ml, caused a nearly 2-fold increase in the percentage of Leydig cell progenitors after 8 days of culture. Immunohistochemical double labelling experiments with 3beta-HSD and BrdU antibodies showed that this increase was the result of differentiation of stem Leydig cells/precursor cells and not caused by proliferation of progenitor cells themselves. The addition of LH to the cultures consistently resulted in an increase in progenitor formation throughout the culture period. Surprisingly, when OSM and LH were added together, the LH induced rise in progenitor cells was significantly inhibited after 3 and 8 days of culture. CONCLUSION: Taken together, the results of the present study suggest that locally produced OSM may not only play a role in the regulation of Sertoli cell proliferation and the initiation of spermatogenesis but may also play a role in the regulation of Leydig cell progenitor formation by keeping the augmenting effects of LH on this process in abeyance.
format Text
id pubmed-2174940
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21749402008-01-05 Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro Teerds, Katja J van Dissel-Emiliani, Federica MF De Miguel, Maria P de Boer-Brouwer, Mieke Körting, Lina M Rijntjes, Eddy Reprod Biol Endocrinol Research BACKGROUND: The initial steps of stem Leydig cell differentiation into steroid producing progenitor cells are thought to take place independent of luteinizing hormone (LH), under the influence of locally produced factors such as leukaemia inhibitory factor (LIF), platelet derived growth factor A and stem cell factor. For the formation of a normal sized Leydig cell population in the adult testis, the presence of LH appears to be essential. Oncostatin M (OSM) is a multifunctional cytokine and member of the interleukin (IL)-6 family that also includes other cytokines such as LIF. In the rat OSM is highly expressed in the late fetal and neonatal testis, and may thus be a candidate factor involved in Leydig cell progenitor formation. METHODS: Interstitial cells were isolated from 13-day-old rat testes and cultured for 1, 3 or 8 days in the presence of different doses of OSM (range: 0.01 to 10 ng/ml) alone or in combination with LH (1 ng/ml). The effects of OSM and LH on cell proliferation were determined by incubating the cultures with [3H]thymidine or bromodeoxyuridine (BrdU). Developing progenitor cells were identified histochemically by the presence of the marker enzyme 3beta-hydroxysteroid dehydrogenase (3beta-HSD). RESULTS: OSM, when added at a dose of 10 ng/ml, caused a nearly 2-fold increase in the percentage of Leydig cell progenitors after 8 days of culture. Immunohistochemical double labelling experiments with 3beta-HSD and BrdU antibodies showed that this increase was the result of differentiation of stem Leydig cells/precursor cells and not caused by proliferation of progenitor cells themselves. The addition of LH to the cultures consistently resulted in an increase in progenitor formation throughout the culture period. Surprisingly, when OSM and LH were added together, the LH induced rise in progenitor cells was significantly inhibited after 3 and 8 days of culture. CONCLUSION: Taken together, the results of the present study suggest that locally produced OSM may not only play a role in the regulation of Sertoli cell proliferation and the initiation of spermatogenesis but may also play a role in the regulation of Leydig cell progenitor formation by keeping the augmenting effects of LH on this process in abeyance. BioMed Central 2007-11-08 /pmc/articles/PMC2174940/ /pubmed/17996055 http://dx.doi.org/10.1186/1477-7827-5-43 Text en Copyright © 2007 Teerds et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Teerds, Katja J
van Dissel-Emiliani, Federica MF
De Miguel, Maria P
de Boer-Brouwer, Mieke
Körting, Lina M
Rijntjes, Eddy
Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro
title Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro
title_full Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro
title_fullStr Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro
title_full_unstemmed Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro
title_short Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro
title_sort oncostatin-m inhibits luteinizing hormone stimulated leydig cell progenitor formation in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174940/
https://www.ncbi.nlm.nih.gov/pubmed/17996055
http://dx.doi.org/10.1186/1477-7827-5-43
work_keys_str_mv AT teerdskatjaj oncostatinminhibitsluteinizinghormonestimulatedleydigcellprogenitorformationinvitro
AT vandisselemilianifedericamf oncostatinminhibitsluteinizinghormonestimulatedleydigcellprogenitorformationinvitro
AT demiguelmariap oncostatinminhibitsluteinizinghormonestimulatedleydigcellprogenitorformationinvitro
AT deboerbrouwermieke oncostatinminhibitsluteinizinghormonestimulatedleydigcellprogenitorformationinvitro
AT kortinglinam oncostatinminhibitsluteinizinghormonestimulatedleydigcellprogenitorformationinvitro
AT rijntjeseddy oncostatinminhibitsluteinizinghormonestimulatedleydigcellprogenitorformationinvitro